rawfin.tv
Maze Therapeutics Stock Plummets to 52-Week Low
MarketsstocksAI Generated

Maze Therapeutics Stock Plummets to 52-Week Low

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Maze Therapeutics Inc. shares have fallen to a 52-week low of $22.44, representing a 58% decline from its previous high. This significant drop signals investor concerns regarding the biotechnology company.

biotechnologystock performance52-week lowmarket data

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks